NO994722L - Ernaeringsformuleringer inneholdende Lacto-N-neotetraose - Google Patents

Ernaeringsformuleringer inneholdende Lacto-N-neotetraose

Info

Publication number
NO994722L
NO994722L NO994722A NO994722A NO994722L NO 994722 L NO994722 L NO 994722L NO 994722 A NO994722 A NO 994722A NO 994722 A NO994722 A NO 994722A NO 994722 L NO994722 L NO 994722L
Authority
NO
Norway
Prior art keywords
neotetraose
formulations containing
nutritional formulations
lacto
containing lacto
Prior art date
Application number
NO994722A
Other languages
English (en)
Other versions
NO994722D0 (no
NO315254B1 (no
Inventor
Pedro A Prieto
Terry A Kroening
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253891&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO994722(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO994722L publication Critical patent/NO994722L/no
Publication of NO994722D0 publication Critical patent/NO994722D0/no
Publication of NO315254B1 publication Critical patent/NO315254B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • General Preparation And Processing Of Foods (AREA)
NO19994722A 1997-03-31 1999-09-28 Ern¶ringsformuleringer inneholdende Lacto-N-neotetraose NO315254B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/829,220 US5906982A (en) 1997-03-31 1997-03-31 Nutritional formulations containing Lacto-N-neoTetraose
PCT/US1998/006217 WO1998043495A1 (en) 1997-03-31 1998-03-30 Nutritional formulations containing lacto-n-neotetraose

Publications (3)

Publication Number Publication Date
NO994722L true NO994722L (no) 1999-09-28
NO994722D0 NO994722D0 (no) 1999-09-28
NO315254B1 NO315254B1 (no) 2003-08-11

Family

ID=25253891

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994722A NO315254B1 (no) 1997-03-31 1999-09-28 Ern¶ringsformuleringer inneholdende Lacto-N-neotetraose

Country Status (11)

Country Link
US (2) US5906982A (no)
EP (1) EP0973413B2 (no)
JP (1) JP4148535B2 (no)
AT (1) ATE271788T1 (no)
CA (1) CA2285066C (no)
DE (1) DE69825260T3 (no)
DK (1) DK0973413T4 (no)
ES (1) ES2229486T5 (no)
NO (1) NO315254B1 (no)
PT (1) PT973413E (no)
WO (1) WO1998043495A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6375994B1 (en) * 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
EP1332759B1 (en) * 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
US20040047866A1 (en) * 2002-09-09 2004-03-11 President And Fellows Of Harvard College Immunomodulatory methods using carbohydrate antigens
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
DK1629850T4 (da) 2004-08-24 2013-07-01 Nutricia Nv Næringssammensætning indeholdende ufordøjelige oligosaccharider
CN101155516B (zh) * 2005-04-08 2012-10-03 雪印惠乳业株式会社 含乳蛋白的铁组合物
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
AU2008324105B2 (en) * 2007-11-08 2014-01-30 Société des Produits Nestlé S.A. Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
KR20190000937A (ko) * 2009-02-24 2019-01-03 리터 파마슈티컬즈 인코오포레이티드 프리바이오틱 제제 및 사용 방법
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
WO2012092082A1 (en) * 2010-12-30 2012-07-05 Abbott Laboratories Reduced buffering capacity of a low calorie infant formula
EP3335576A1 (en) 2010-12-31 2018-06-20 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
WO2012092155A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
NZ613180A (en) 2010-12-31 2015-02-27 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
CN103379908B (zh) 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
WO2012092157A2 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
EP3338784B1 (en) 2010-12-31 2020-07-22 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
CN107595860A (zh) 2011-07-22 2018-01-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
MY169326A (en) 2011-08-29 2019-03-21 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
AU2012324993B2 (en) * 2011-10-18 2015-11-26 Société des Produits Nestlé S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
EP2842560A4 (en) * 2012-04-23 2015-12-02 Univ Kyoto COMPOSITION FOR PROMOTING BIFIDOBACTERIUM GROWTH
CA2894897C (en) * 2012-12-20 2018-09-18 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10828313B2 (en) 2014-12-08 2020-11-10 Glycom A/S Synthetic composition for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) * 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
FI3264923T3 (fi) 2015-03-05 2023-04-21 Nestle Sa Koostumuksia käytettäväksi ruoansulatuskanavan infektioiden ehkäisemisessä tai hoitamisessa imeväisillä tai nuorilla lapsilla
AU2016303000B2 (en) 2015-08-04 2021-01-21 Société des Produits Nestlé S.A. Nutritional compositions with 2FL and LNnT for use in inducing a gut microbiota close to the one of breast fed infants
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
CN109562117A (zh) 2016-08-04 2019-04-02 雀巢产品技术援助有限公司 具有2FL和LNnT的营养组合物，用于通过作用于肠道微生物群生态失调来预防和/或治疗非轮状病毒腹泻
WO2024024906A1 (ja) * 2022-07-29 2024-02-01 森永乳業株式会社 ビフィドバクテリウム・ブレーベのオリゴ糖資化促進用組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE518409A (no) *
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE462134B (sv) * 1987-10-22 1990-05-14 Biocarb Ab Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
EP0481038B1 (en) * 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CA2184688A1 (en) * 1994-03-09 1995-09-14 Pedro Antonio Prieto Transgenic animals producing oligosaccharides and glycoconjugates
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose

Also Published As

Publication number Publication date
CA2285066A1 (en) 1998-10-08
DE69825260T2 (de) 2005-08-04
EP0973413A1 (en) 2000-01-26
ATE271788T1 (de) 2004-08-15
DK0973413T4 (da) 2012-02-27
ES2229486T5 (es) 2012-01-10
NO994722D0 (no) 1999-09-28
WO1998043495A1 (en) 1998-10-08
DE69825260D1 (de) 2004-09-02
US6083934A (en) 2000-07-04
DK0973413T3 (da) 2004-11-29
ES2229486T3 (es) 2005-04-16
JP2001517950A (ja) 2001-10-09
DE69825260T3 (de) 2012-04-26
CA2285066C (en) 2010-06-08
NO315254B1 (no) 2003-08-11
PT973413E (pt) 2004-11-30
EP0973413B1 (en) 2004-07-28
EP0973413B2 (en) 2011-11-09
US5906982A (en) 1999-05-25
JP4148535B2 (ja) 2008-09-10

Similar Documents

Publication Publication Date Title
NO994722L (no) Ernaeringsformuleringer inneholdende Lacto-N-neotetraose
MY115662A (en) Novel compounds with analgesic effect
GEP20032938B (en) Acaricide
WO1992019104A3 (en) Fatty acid based compositions for the control of established plant infections
ES2191066T3 (es) Preparacion enantioselectiva de sulfoxidos farmaceuticamente activos por biooxidacion.
RS50035B (sr) Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
GR3007385T3 (no)
ES8802420A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
MY101600A (en) An agricultural composition with reduced toxicity to fishes and shellfishes.
PL324625A1 (en) Fungicidal compositions
GR20030100300A (el) Φαρμακευτικες συνθεσεις με αντιβιοτικη δραση
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
ATE227122T1 (de) Stabilisierte tablettenformulierung
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
BR9609114A (pt) Composição inseticida de terra diatomácea
JPS542337A (en) Bactericidal composition for medical use
PL285802A1 (en) Acaricidal composition, method of obtaining an active acaricidal agent as well as method of obtaining and maintaining a novel bacterial strain or mixed micropopulation
AU6722498A (en) Disubstituted biphenyloxazolines
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
AU3903701A (en) Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
GEP20002242B (en) Herbicidal 3,5-Difluoropyridines
JPS52156995A (en) Microbial preparation of l-lysine

Legal Events

Date Code Title Description
MK1K Patent expired